Gonadorelin
FDA ApprovedGonadorelin (GnRH)
- Category
- Sexual Health
- Aliases
- GnRH, LHRH, Factrel
- Administration
- Subcutaneous injection, Intravenous (diagnostic use)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Because it acts through a single, fast hormone pulse rather than a sustained buildup, most users don't describe a distinct day-to-day sensation this early in a fertility-support protocol.
- 2
3–4 Weeks
Continued pulsatile dosing is generally required before meaningful hormonal changes are expected.
- 3
5–7 Weeks
Fertility-focused users at this stage often begin monitoring relevant lab markers alongside any felt changes.
- 4
8–10 Weeks
Effects, where present, tend to be gradual rather than sudden, tracked through lab work rather than day-to-day sensation.
- 5
11–15 Weeks
Long-term users typically evaluate outcomes through fertility-related lab markers monitored by a physician.
- 6
16–20 Weeks
Available evidence does not describe a distinct felt sensation at this duration; monitoring remains lab-based.
- 7
21–24 Weeks
By this stage, most users are evaluating outcomes in consultation with a physician rather than relying on felt sensation alone.
⚠️ Research context only. This is not medical advice and results are not guaranteed.